» Articles » PMID: 25932440

Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection

Overview
Journal Ann Lab Med
Specialty Pathology
Date 2015 May 2
PMID 25932440
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although single antigen bead assays (SAB) are approved qualitative tests, the median fluorescence intensity (MFI) values obtained from SAB are frequently used in combination with quantitative significances for diagnostic purposes. To gauge the reproducibility of SAB results, we assessed the interlaboratory variability of MFI values using identical kits with reagents from the same lot and the manufacturer's protocol.

Methods: Six serum samples containing HLA-specific antibodies were analyzed at five laboratories by using Lifecodes LSA Class I and Class II SAB kits (Immucor, USA) from the same lot, according to the manufacturer's protocol. We analyzed the concordance of qualitative results according to distinct MFI cutoffs (1,000, 3,000, 5,000, and 10,000), and the correlation of quantitative MFI values obtained by the participating laboratories. The CV for MFI values were analyzed and grouped by mean MFI values from the five laboratories (<1,000; 1,000-2,999; 3,000-4,999; 5,000-9,999; and ≥10,000).

Results: The categorical results obtained from the five laboratories exhibited concordance rates of 96.0% and 97.2% for detection of HLA class I and class II antibodies, respectively. The Pearson correlation coefficients for MFI values of class I and class II antibodies were between 0.947-0.991 and 0.992-0.997, respectively. The median CVs for the MFI values among five laboratories in the lower MFI range (<1,000) were significantly higher than those for the other MFI ranges (all P<0.01).

Conclusions: Analysis of SAB performed in five laboratories using identical protocols and reagents from the same lot resulted in high levels of concordance and strong correlation of results.

Citing Articles

Anti-Human Leukocyte Antigen Antibody Detection from Terasaki's Humoral Theory to Delisting Strategies in 2024.

San Segundo D, Comins-Boo A, Lopez-Hoyos M Int J Mol Sci. 2025; 26(2).

PMID: 39859344 PMC: 11766285. DOI: 10.3390/ijms26020630.


Virtual crossmatch-prodigal saviour of cardiac transplants in India.

Meeran T, Mulay A, Gaur A, Sinha S, Basavanna R Indian J Thorac Cardiovasc Surg. 2021; 37(3):351-353.

PMID: 33967431 PMC: 8079499. DOI: 10.1007/s12055-020-01103-y.


Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A.

Dissanayake K, Jayasinghe C, Wanigasekara P, Sominanda A PLoS One. 2021; 16(1):e0246111.

PMID: 33497394 PMC: 7837465. DOI: 10.1371/journal.pone.0246111.


EDTA Treatment for Overcoming the Prozone Effect and for Predicting C1q Binding in HLA Antibody Testing.

Kim H, Choi A, Yang M, Oh E Ann Lab Med. 2019; 39(6):572-576.

PMID: 31240886 PMC: 6660344. DOI: 10.3343/alm.2019.39.6.572.


Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.

Lee H, Han E, Choi A, Ban T, Chung B, Yang C PLoS One. 2018; 13(11):e0207434.

PMID: 30427941 PMC: 6235372. DOI: 10.1371/journal.pone.0207434.


References
1.
Reinsmoen N, Lai C, Vo A, Cao K, Ong G, Naim M . Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation. 2008; 86(6):820-5. DOI: 10.1097/TP.0b013e3181856f98. View

2.
Burns J, Cornell L, Perry D, Pollinger H, Gloor J, Kremers W . Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant. 2008; 8(12):2684-94. DOI: 10.1111/j.1600-6143.2008.02441.x. View

3.
Wortley A, Mckinley K, Whittle R, Calvert A, Shaw O, Fernando R . Investigations into the lack of consensus in the reporting of HLA antibody specificities in the UK. J Clin Pathol. 2009; 62(3):270-4. DOI: 10.1136/jcp.2008.061259. View

4.
Bray R, Gebel H . Strategies for human leukocyte antigen antibody detection. Curr Opin Organ Transplant. 2009; 14(4):392-7. DOI: 10.1097/mot.0b013e32832d31c7. View

5.
Tambur A, Ramon D, Kaufman D, Friedewald J, Luo X, Ho B . Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations. Am J Transplant. 2009; 9(8):1886-93. PMC: 4094140. DOI: 10.1111/j.1600-6143.2009.02724.x. View